Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996

被引:12
作者
Butler, DL
Gagnon, RC
Miller, LA
Poupard, JA
Felmingham, D
Gruneberg, RN
机构
[1] SmithKline Beecham Pharmaceut, Dept Antiinfect, Collegeville, PA 19426 USA
[2] SmithKline Beecham Pharmaceut, Biostat & Data Sci, Collegeville, PA 19426 USA
[3] GR Micro Ltd, London, England
关键词
D O I
10.1093/jac/43.6.777
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A number of published studies have shown that the MICs of amoxycillin and/or co-amoxyclav are lower than those of ampicillin and/or penicillin for Streptococcus pneumoniae. Other published studies have concluded that the activities of amoxycillin and co-amoxyclav are comparable with that of penicillin for S. pneumoniae. A collection of 5252 S. pneumoniae isolates obtained during a 5 year period (1992-1996) was analysed to determine differences between the MICs of penicillin, amoxycillin and co-amoxyclav. Among the isolates analysed, 3788 (72%) were penicillin-susceptible, 615 (12%) were penicillin-intermediate and 849 (16%) were penicillin-resistant. Differences between the agents were assessed by examination of MIC distribution functions and simultaneous 95% CIs. In addition, penicillin-intermediate and resistant isolates were analysed to determine the number and percentage of isolates which had an amoxycillin and co-amoxyclav MIC less than, equal to, or greater than the penicillin MIC. Results showed that the amoxycillin and co-amoxyclav MIC(90)s were one two-fold dilution lower than those of penicillin for all isolates collected between 1992-1993 and 1994-1996. Simultaneous 95% CIs showed that the mean differences between MICs of amoxycillin and penicillin, and between MICs of co-amoxyclav and penicillin, were less than zero. The majority of the penicillin-intermediate and penicillin-resistant isolates had an amoxycillin and co-amoxyclav MIC less than the penicillin MIC. In conclusion, amoxycillin and co-amoxyclav MICs were shown to be lower than the penicillin MICs for the S. pneumoniae isolates analysed in this study.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 18 条
[1]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[2]   Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study [J].
Doern, GV ;
Brueggemann, A ;
Holley, HP ;
Rauch, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1208-1213
[3]  
Drusano GL, 1997, J CHEMOTHERAPY, V9, P38
[4]  
GOLDSTEIN FW, 1992, 32 INT C ANT AG CHEM, P281
[5]   Results of the Alexander project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens [J].
Gruneberg, RN ;
Felmingham, D ;
Acar, J ;
Lemozy, J ;
Bauernfeind, A ;
Grimm, H ;
Schito, GC ;
Russo, G ;
Baquero, F ;
Louzao, JL ;
Gruneberg, R ;
Murphy, P ;
Neu, H ;
Berk, S ;
Pfaller, M ;
Sewell, D ;
Doern, G .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (04) :169-181
[6]  
JONES RN, 1997, 37 INT C ANT AG CHEM, P133
[7]   ANTIMICROBIAL RESISTANCE AMONG RESPIRATORY ISOLATES OF HAEMOPHILUS-INFLUENZAE, MORAXELLA-CATARRHALIS, AND STREPTOCOCCUS-PNEUMONIAE IN THE UNITED-STATES [J].
JORGENSEN, JH ;
DOERN, GV ;
MAHER, LA ;
HOWELL, AW ;
REDDING, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2075-2080
[8]  
KORGENSKI EK, 1997, 97 GEN M AM SOC MICR, P171
[9]  
LARSON HJ, 1982, PROBABILITY THEORY S
[10]  
*NAT COMM CLIN LAB, 1995, PERF STAND ANT SUSC